Edesa Biotech
EDSA
10 hedge funds and large institutions have $71.1K invested in Edesa Biotech in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more ownership
Funds ownership: 0% → 0% (+0%)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
96% less capital invested
Capital invested by funds: $1.83M → $71.1K (-$1.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAS
WESPAC Advisors SoCal
Pasadena,
California
|
+$4.31K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.85K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$616 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.71M |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$27.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5.54K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
Advisor Group
Phoenix,
Arizona
| $53K | -$27.7K | -45 | -34% |
|
|
WAS
2
WESPAC Advisors SoCal
Pasadena,
California
| $4.06K | +$4.31K | +7 | New |
|
|
3
Creative Planning
Overland Park,
Kansas
| $4K | +$616 | +1 | +17% |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | -$5.54K | -9 | -69% |
|
|
CFD
5
Creative Financial Designs
Kokomo,
Indiana
| $2K | +$1.85K | +3 | New |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.85K | +3 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
EDRH
8
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $1K | – | – | – |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
WAM
10
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| $1K | – | – | – |
|
|
AFM
11
Anson Funds Management
Dallas,
Texas
| – | -$1.71M | -2,426 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$1K | -2 | Closed |
|
EDSA Hedge Fund Activity: Q4 2016 in Review
10 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2016, worth a combined $71.1K — down 96% from $1.83M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new EDSA positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was WESPAC Advisors SoCal, opening a new position worth an estimated $4.31K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.71M sold.
- 10 institutional investors held Edesa Biotech (EDSA) as of Q4 2016, down from 12 in Q3 2016.
- Funds reported $71.1K of Edesa Biotech stock for Q4 2016, down 96% quarter-over-quarter.
- 3 funds opened new Edesa Biotech positions in Q4 2016 and 2 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q4 2016 was WESPAC Advisors SoCal, an estimated $4.31K added.
- The largest Edesa Biotech seller in Q4 2016 was Anson Funds Management, an estimated $1.71M sold.
Based on aggregated 13F filings for Q4 2016.